LGMD gene therapy company secure $2.5m funding

Myonexus Therapeutics has announced that it has secured $2.5 million to advance limb girdle muscular dystrophy (LGMD) gene therapies into the clinic.

Read more
Keep in touch
X
- Enter Your Location -
- or -